Have you been primarily focused on genomics, pathology, liquid biopsies, flow cytometry, spatial biology, or omics data this year?
The 15th World Clinical Biomarkers & Companion Diagnostics Summit Europe (8-10th April, London) is an important event for advancing precision treatments in the European market.
Check out a sneak preview of the agenda below.
- Advancing Faster Diagnosis of Pancreatic & Biliary Tract Cancers with Liquid Biopsies
This talk is hosted by Naureen Starling, a Medical Oncologist specializing in gastrointestinal (GI) cancers and the Director of the Royal Marsden’s Clinical Trials Unit. She also serves as an NIHR Professor of Gastrointestinal Oncology at The Royal Marsden NHS Foundation Trust.
- Developing Blood-based Biomarkers to Stratify Alzheimer's Patients
Featuring Mario Richter, Senior Director of Development Sciences at AbbVie.
- A Match Made in Oncology: Optimizing Co-Development Partnerships
Led by Antje Lukas, Senior Director of Regulatory Affairs for Companion Diagnostics at Daiichi Sankyo Europe.
- Define a Unified Path to IVDR Compliance for Streamlined Approvals
With participation from AstraZeneca, Bayer, and TÜV SÜD.
Bring your expertise to the conversation and join 170+ senior industry executives in advancing IVDR-compliant drug-diagnostic solutions for the European market. Explore how data-driven insights are improving patient outcomes in oncology, metabolic disorders, rare diseases, and autoimmune conditions.
About Hanson Wade Group - 15th World Clinical Biomarkers & CDx Europe
Welcome to the 15th World Clinical Biomarkers & Companion Diagnostics Summit Europe.
With drug-diagnostic co-development partnerships fueling advances in diagnostic testing for Alzheimer’s, Multiple Sclerosis, cardiovascular disease, rare genetic disorders, and cancer, 2025 is poised as a critical year for Europe’s precision medicine community. However, developing, clinically validating, regulatory filing, and commercializing biomarkers and in vitro diagnostics remains no easy feat, as knowledge gaps persist in validating surrogate endpoints, co-developing scalable diagnostic testing workflows and infrastructure, navigating reimbursement pathways, and harmonizing drug-diagnostic IVDR-adherence for approval in unmet patient need.
The 15th World Clinical Biomarkers & Companion Diagnostics Summit Europe returns as the industry-leading end-to-end forum for Europe’s precision medicine community. Serving as your premium connection-making platform, this summit will unite over 170 key European stakeholders to accelerate precision drugs from discovery through to commercialization for patients in need.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.